MAX - SHOCK Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.
Also called NCT06556667
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 376 participants
- Registry
-
NCT06556667
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06556667. Randomized; single masking; primary purpose treatment. Start 2025-03-31 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MAX - SHOCK Clinical Trial
- Acronym
- MAX-SHOCK
- Condition
- Cardioversion
- Condition
- Atrial Fibrillation
- Intervention (Device)
- biphasic defibrillator with maximum energy of 200J (® Zoll)
- Intervention (Device)
- biphasic defibrillator with maximum energy of 360J (® Physio-Control)
- Lead sponsor
- Ottawa Heart Institute Research Corporation
Record details
- Record id
cardio:ct-nct06556667- Content hash
99f34167040d77a9158ee622d3966a3d53e1d76de429d4a2468cd52e13464a96